129 related articles for article (PubMed ID: 2180328)
1. Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects.
Peselow ED; Robins C; Block P; Barouche F; Fieve RR
Am J Psychiatry; 1990 Apr; 147(4):439-44. PubMed ID: 2180328
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional attitudes in major depression. Changes with pharmacotherapy.
Fava M; Bless E; Otto MW; Pava JA; Rosenbaum JF
J Nerv Ment Dis; 1994 Jan; 182(1):45-9. PubMed ID: 8277301
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
4. DST results in nonpsychotic depressed outpatients.
Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
[TBL] [Abstract][Full Text] [Related]
5. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
Stewart JW; McGrath PJ; Quitkin FM
Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
8. Trimipramine in physical illness with depression.
Rifkin A; Reardon G; Siris S; Karagji B; Kim YS; Hackstaff L; Endicott N
J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):4-8. PubMed ID: 3881418
[TBL] [Abstract][Full Text] [Related]
9. The Tridimensional Personality Questionnaire in major depression.
Joffe RT; Bagby RM; Levitt AJ; Regan JJ; Parker JD
Am J Psychiatry; 1993 Jun; 150(6):959-60. PubMed ID: 8494077
[TBL] [Abstract][Full Text] [Related]
10. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
Zimmerman M; Mattia JI; Posternak MA
Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
[TBL] [Abstract][Full Text] [Related]
11. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
[TBL] [Abstract][Full Text] [Related]
12. Eighteen months of drug treatment for depression: predicting relapse and recovery.
Mulder RT; Frampton CM; Luty SE; Joyce PR
J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
[TBL] [Abstract][Full Text] [Related]
13. Bupropion in depression: a tri-center placebo-controlled study.
Pitts WM; Fann WE; Halaris AE; Dressler DM; Sajadi C; Snyder S; Ilaria RL
J Clin Psychiatry; 1983 May; 44(5 Pt 2):95-100. PubMed ID: 6406473
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
Georgia EH
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
[TBL] [Abstract][Full Text] [Related]
16. Stability of dysfunctional attitudes and early maladaptive schemas: a 9-year follow-up study of clinically depressed subjects.
Wang CE; Halvorsen M; Eisemann M; Waterloo K
J Behav Ther Exp Psychiatry; 2010 Dec; 41(4):389-96. PubMed ID: 20452570
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of bupropion and amitriptyline in depressed outpatients.
Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
[TBL] [Abstract][Full Text] [Related]
18. Melancholic/endogenous depression and response to somatic treatment and placebo.
Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
[TBL] [Abstract][Full Text] [Related]
19. Review of placebo-controlled trials with bupropion.
Zung WW
J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
[TBL] [Abstract][Full Text] [Related]
20. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
Khan A; Brodhead AE; Kolts RL; Brown WA
J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
